FREIBURG, Germany and NOIDA, India, Oct. 24, 2025 /PRNewswire/ -- In a major step toward strengthening Indo-German collaboration, IndiaWorks Energy GmbH…
ISLAMABAD, Oct. 24, 2025 /PRNewswire/ -- MindHYVE.ai™, a global leader in agentic artificial intelligence and adaptive learning technologies, has announced…
RESTON, VA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- K12, a national leader in online learning for 25 years, has earned…
Washington D.C., Oct. 24, 2025 (GLOBE NEWSWIRE) -- The strategic partnership between two global players, Hera Enterprises and Circular Protocol,…
Surfshark, a cybersecurity company, launches a new feature called the web content blocker that focuses on safeguarding every household when…
Major Acquisition Deal Originated at 2024 Event Highlights Conference's Role as Premier Investment Platform HONG KONG, Oct. 9, 2025 /PRNewswire/…
October 24, 2025 12:00 ET | Source: Flare Therapeutics Inc. FX-909, the first small molecule targeting PPARG to be tested…
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including confirmed responses…
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…
NANTONG, China, Oct. 24, 2025 /PRNewswire/ -- On September 24, 2025, the 20th Asia Brand Summit took place in Hong…